Online Exclusive Article

Cryotherapy Effect on Oral Mucositis Severity Among Recipients of Bone Marrow Transplantation: A Literature Review

Abdel-Qader Mahmoud Tayyem

cryotherapy, oral cryotherapy, myeloablative, bone marrow transplantation, hematopoietic stem cell transplantation, oral mucositis, prevention
CJON 2014, 18(4), E84-E87. DOI: 10.1188/14.CJON.E84-E87

Oral mucositis is a distressing toxic effect of cancer therapy and one of the major side effects of the myeloablative conditioning used to prepare patients for bone marrow transplantation (BMT). Oral cryotherapy is one of the recent modalities used to prevent and manage oral mucositis. The purpose of this review is to clarify the cryotherapy effect on oral mucositis severity among patients receiving myeloablative conditioning followed by BMT. A literature search was performed using six different electronic databases: CINAHL®, MEDLINE®, Nursing Ovid, PubMed, Springer, and Science Direct. Six articles were deemed relevant and included in this review. Oral mucositis increases mortality rate, length of hospital stay, opioid use, and the need for parenteral nutrition usage. It also decreases patient's quality of life and his or her desire to complete treatment. However, oral cryotherapy significantly minimizes the incidence and severity of oral mucositis and decreases secondary oral mucositis complications. Using oral cryotherapy concurrently with a regular oral care protocol can improve its efficacy for preventing and managing oral mucositis. Additional studies should be conducted to create standard oral cryotherapy protocols.

Members Only
Not a current ONS member or journal subscriber?

Purchase This Article

Receive a PDF to download and print.